中国免疫学杂志
中國免疫學雜誌
중국면역학잡지
CHINESE JOURNAL OF IMMUNOLOGY
2014年
12期
1596-1600
,共5页
刘彦礼%牛荣成%徐明恺%李旭%苏振成%张惠文
劉彥禮%牛榮成%徐明愷%李旭%囌振成%張惠文
류언례%우영성%서명개%리욱%소진성%장혜문
金黄色葡萄球菌肠毒素C2%超抗原%T淋巴细胞%细胞因子
金黃色葡萄毬菌腸毒素C2%超抗原%T淋巴細胞%細胞因子
금황색포도구균장독소C2%초항원%T림파세포%세포인자
Staphylococcal enterotoxin C 2%Superantigen%T cell%Cytokine
目的:揭示突变蛋白SEC2(T20L/G22E)超抗原活性较野生型SEC2显著增强的潜在机制。方法:WST-1法检测突变蛋白SEC2(T20L/G22E)在体外刺激小鼠脾淋巴细胞增殖活性,进一步应用流式细胞术和荧光定量PCR技术分别检测CD4+和CD8+T淋巴细胞增殖、特异性VβT淋巴细胞增殖以及相关细胞因子mRNA丰度变化。结果:与野生型SEC2相比,突变蛋白SEC2(T20L/G22E)能够在体外显著刺激小鼠脾淋巴细胞增殖,但二者具有相似的特异性VβT淋巴细胞增殖谱,并且SEC2( T20L/G22E)能够较rSEC2激活更多携带有Vβ5.3、Vβ8.1及Vβ8.3的T 淋巴细胞;进一步体内实验发现 SEC2(T20L/G22E)能够较rSEC2激活更多外周血和脾脏中CD4+和CD8+T淋巴细胞增殖及相关细胞因子的表达。结论:突变蛋白SEC2(T20L/G22E)超抗原活性增强的机制可能是用亮氨酸和谷氨酸替代原来20和22位上的氨基酸后提高了SEC2(T20L/G22 E)与特异性TCR-Vβ的亲和力,进一步激活更多的SEC2特异性T淋巴细胞,最终引起T淋巴细胞亚型的显著性增殖,同时诱导更多与抗肿瘤、增殖相关的细胞因子的表达。
目的:揭示突變蛋白SEC2(T20L/G22E)超抗原活性較野生型SEC2顯著增彊的潛在機製。方法:WST-1法檢測突變蛋白SEC2(T20L/G22E)在體外刺激小鼠脾淋巴細胞增殖活性,進一步應用流式細胞術和熒光定量PCR技術分彆檢測CD4+和CD8+T淋巴細胞增殖、特異性VβT淋巴細胞增殖以及相關細胞因子mRNA豐度變化。結果:與野生型SEC2相比,突變蛋白SEC2(T20L/G22E)能夠在體外顯著刺激小鼠脾淋巴細胞增殖,但二者具有相似的特異性VβT淋巴細胞增殖譜,併且SEC2( T20L/G22E)能夠較rSEC2激活更多攜帶有Vβ5.3、Vβ8.1及Vβ8.3的T 淋巴細胞;進一步體內實驗髮現 SEC2(T20L/G22E)能夠較rSEC2激活更多外週血和脾髒中CD4+和CD8+T淋巴細胞增殖及相關細胞因子的錶達。結論:突變蛋白SEC2(T20L/G22E)超抗原活性增彊的機製可能是用亮氨痠和穀氨痠替代原來20和22位上的氨基痠後提高瞭SEC2(T20L/G22 E)與特異性TCR-Vβ的親和力,進一步激活更多的SEC2特異性T淋巴細胞,最終引起T淋巴細胞亞型的顯著性增殖,同時誘導更多與抗腫瘤、增殖相關的細胞因子的錶達。
목적:게시돌변단백SEC2(T20L/G22E)초항원활성교야생형SEC2현저증강적잠재궤제。방법:WST-1법검측돌변단백SEC2(T20L/G22E)재체외자격소서비림파세포증식활성,진일보응용류식세포술화형광정량PCR기술분별검측CD4+화CD8+T림파세포증식、특이성VβT림파세포증식이급상관세포인자mRNA봉도변화。결과:여야생형SEC2상비,돌변단백SEC2(T20L/G22E)능구재체외현저자격소서비림파세포증식,단이자구유상사적특이성VβT림파세포증식보,병차SEC2( T20L/G22E)능구교rSEC2격활경다휴대유Vβ5.3、Vβ8.1급Vβ8.3적T 림파세포;진일보체내실험발현 SEC2(T20L/G22E)능구교rSEC2격활경다외주혈화비장중CD4+화CD8+T림파세포증식급상관세포인자적표체。결론:돌변단백SEC2(T20L/G22E)초항원활성증강적궤제가능시용량안산화곡안산체대원래20화22위상적안기산후제고료SEC2(T20L/G22 E)여특이성TCR-Vβ적친화력,진일보격활경다적SEC2특이성T림파세포,최종인기T림파세포아형적현저성증식,동시유도경다여항종류、증식상관적세포인자적표체。
Objective:To investigate the improved superantigen activity of SEC2(T20L/G22E) compared with recombinant staphylococcal enterotoxins C 2 ( rSEC2 ).Methods: The proliferation of spleen lymphocytes and T-cell subpopulations induced by rSEC2 and SEC2(T20L/G22E) were examined by WST-1 and flow cytometry separately,and the gene expression of cytokines and Vβspecificities were quantified by real-time PCR.Results: WST-1 and Flow cytometry assays showed that the superantigen activity of SEC2(T20L/G22E) was improved due to enhanced T-cell stimulating potency,resulting in massive activation of T-cells,particularly CD4+and CD8+T-cells.Quantitative real-time PCR assay showed that despite similar Vβspecificities induced by rSEC 2 and SEC2 (T20L/G22E),the quantities of activated T-cells bearing specific Vβwere different,and SEC2(T20L/G22E) could stimulate more gene expression of associated cytokines simultaneously.Conclusion: The results strongly suggested that the increased SEC 2 ( T20L/G22 E)-TCR-binding affinity contributed to more T-cells activation and cytokine release ,which elicit powerful immune activition.